Nalmefene, Given as Needed, in the Routine Treatment of Patients with Alcohol Dependence: An Interventional, Open-Label Study in Primary Care

Autor: Castera, P, Stewart, E, Grosskopf, J, Brotons, C, Schou, MB, Zhang, D, Brach, BS, Meulien, D, PICASO Study Investigators

Publikováno v: EUROPEAN ADDICTION RESEARCH
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

Aims: This 12-week, open-label, primary care study (NCT02195817) evaluated the efficacy and safety of nalmefene, taken as needed, to reduce alcohol consumption in adults with a diagnosis of alcohol dependence and drinking at least at high drinking ri

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::b98f64202b8f515da3c35d3eaedb14e7
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=3238